Abstract:Ferroptosis, a therapeutic strategy for tumours, is a regulated cell death characterised by the increased accumulation of iron-dependent lipid peroxides (LPO). Tumour-associated long non-coding RNAs (lncRNAs), when combined with traditional anti-cancer medicines or radiotherapy, can improve efficacy and decrease mortality in cancer. Investigating the role of ferroptosis-related lncRNAs may help strategise new therapeutic options for breast cancer (BC). Herein, we briefly discuss the genes and pathways of ferroptosis involved in iron and reactive oxygen species (ROS) metabolism, including the X C − /GSH/GPX4 system, ACSL4/LPCAT3/15-LOX and FSP1/CoQ10/NAD(P)H pathways, and investigate the correlation between ferroptosis and LncRNA in BC to determine possible biomarkers related to ferroptosis.

What problem does this paper attempt to address?

The paper attempts to address the role and mechanism of ferroptosis and its related long-chain non-coding RNAs (lncRNAs) in breast cancer, and explore their potential as therapeutic targets. Specifically: 1. **The role of ferroptosis in breast cancer**: The paper discusses the importance of ferroptosis as a novel form of cell death in breast cancer. Since ferroptosis is closely related to oxidative stress and cancer cells typically have higher levels of reactive oxygen species (ROS), studying ferroptosis may help develop new anti-cancer strategies. 2. **Identification of ferroptosis-related lncRNAs**: Long-chain non-coding RNAs (lncRNAs) play important roles in cancer, but research on ferroptosis-related lncRNAs is still limited. By analyzing the association between ferroptosis and lncRNAs, new biomarkers and therapeutic targets can be discovered. 3. **Treatment of triple-negative breast cancer (TNBC)**: Triple-negative breast cancer is a difficult-to-treat subtype of breast cancer that is not sensitive to traditional treatments. Studies have found that TNBC is more sensitive to ferroptosis, providing new therapeutic approaches for TNBC. 4. **Potential biomarkers and therapeutic targets**: By exploring the key genes and pathways involved in ferroptosis, such as the XC-/GSH/GPX4 system, ACSL4/LPCAT3/15-LOX pathway, and FSP1/CoQ10/NAD(P)H pathway, the paper aims to identify new biomarkers for the diagnosis and treatment of breast cancer. In summary, this paper aims to reveal the biological significance of ferroptosis and its related lncRNAs in breast cancer, with the goal of providing new theoretical foundations and technical means for the treatment of breast cancer.

Role of ferroptosis and ferroptosis-related long non'coding RNA in breast cancer